Quantbot Technologies’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-500
Closed -$6.42K 1687
2025
Q4
$6.42K Buy
+500
New +$6.17K ﹤0.01% 1613
2024
Q3
Sell
-15,058
Closed -$91.1K 1428
2024
Q2
$91.1K Buy
+15,058
New +$92.9K ﹤0.01% 1140
2024
Q1
Sell
-17,066
Closed -$134K 1524
2023
Q4
$134K Sell
17,066
-54,813
-76% -$380K 0.01% 1106
2023
Q3
$525K Buy
71,879
+50,896
+243% +$423K 0.04% 620
2023
Q2
$219K Buy
+20,983
New +$202K 0.01% 939
2023
Q1
Sell
-16,403
Closed -$226K 1520
2022
Q4
$226K Buy
+16,403
New +$228K 0.02% 854
2020
Q4
Sell
-1,185
Closed -$14K 1262
2020
Q3
$14K Buy
+1,185
New +$11.2K ﹤0.01% 1057
2020
Q1
Sell
-7,974
Closed -$127K 887
2019
Q4
$127K Buy
7,974
+7,774
+3,887% +$119K 0.01% 762
2019
Q3
$3K Buy
+200
New +$3.91K ﹤0.01% 1217

Other funds holding ANGO

Quantbot Technologies's ANGO Position: Q1 2026 in Review

Quantbot Technologies sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 500 shares — an estimated $6.42K sold.

Quantbot Technologies first reported a position in ANGO in Q3 2019 and held it in 9 quarters. The position peaked at $525K in Q3 2023. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Quantbot Technologies reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 500 AngioDynamics shares in Q1 2026, an estimated $6.42K.
  • Quantbot Technologies first reported a position in AngioDynamics in Q3 2019 and held it in 9 quarters.
  • Quantbot Technologies's AngioDynamics position peaked at $525K in Q3 2023.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.